Noteworthy, one of the cell lines from our panel was U2OS, a non-ES osteosarcoma cell line recently identified as being highly sensitive to ATR inhibitors due to its reliance on the ALT pathway for telomere maintenance [28]. The gene discussed is ATR; the disease is osteosarcoma.